Posted on 04/08/05
Be skeptical about the Herceptin hype
The breast cancer drug trastuzumab (better known by its brand name Herceptin) has had more than its share of good press. It has been described as "the biggest cancer breakthrough in a decade," "a life-saving drug" and the "next best thing to a cure."
The full text of this article has 832 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
